IgG F(ab')₂ Fragment from Human Plasma: Key FAQs

Immunoglobulin G (IgG), F (ab')₂ Fragment from Human Plasma is a bivalent antibody fragment preparation derived from FDA-certified donor plasma, manufactured in compliance with current FDA donor screening and viral testing requirements, and widely used as a blocking reagent and research tool in immunological assays.

Product SKU

np001072

Source Material

Human plasma collected from FDA-certified blood collection centers

Fragment Type

F(ab')₂ — bivalent antigen-binding fragment lacking the Fc region

Supplier Reference

Athens Research: 16-16-090707-FAB'2

Regulatory Compliance

Donor screening and viral testing performed per current FDA requirements

Key Advantage

Eliminates Fc-mediated non-specific binding in immunoassays

What Is the IgG F(ab')₂ Fragment and How Is It Produced?

The F(ab')₂ fragment is generated by enzymatic digestion of intact Immunoglobulin G (IgG) molecules, typically using pepsin. This digestion cleaves the antibody below the hinge region disulfide bonds, yielding a bivalent fragment that retains both antigen-binding arms (Fab' units) covalently linked via the hinge disulfide bonds, while removing the Fc region entirely.

Aladdin Scientific's np001072 is derived from human plasma sourced exclusively from FDA-certified blood collection centers. The supplying manufacturer (Athens Research, reference 16-16-090707-FAB'2) performs comprehensive donor screening and viral testing in accordance with current FDA requirements, ensuring a well-characterized and safety-tested starting material.

Because the Fc region is absent, F(ab')₂ fragments cannot interact with Fc receptors on cells or with Fc-binding proteins such as Protein A or Protein G, making them ideal for applications where Fc-mediated interference must be eliminated.

Key Research Applications of Human IgG F(ab')₂ Fragments

Human IgG F(ab')₂ fragments have several well-established uses in research and diagnostic settings:

• Blocking reagent: Used to block non-specific binding of primary or secondary antibodies to human Fc receptors on cell surfaces or in tissue sections, reducing background in immunofluorescence, immunohistochemistry (IHC), and flow cytometry experiments.
• Isotype control: Serves as a human IgG-matched control to assess non-specific binding in assays using human IgG-based antibodies.
• Secondary antibody conjugates: F(ab')₂ fragments conjugated to enzymes or fluorophores are used where Fc-receptor-expressing cells or tissues would otherwise cause high background with intact IgG reagents.
• Complement activation studies: Because F(ab')₂ lacks the Fc region, it does not fix complement, making it useful in studies designed to isolate Fab-mediated effects from Fc effector functions.

Researchers working with human-derived samples or cell lines expressing Fc receptors (e.g., macrophages, dendritic cells, NK cells) particularly benefit from F(ab')₂-based reagents.

Quality, Safety Testing, and Regulatory Compliance

All source plasma used in the manufacture of np001072 is collected from donors at FDA-certified blood collection centers. The supplier performs donor screening and viral testing in accordance with current FDA requirements prior to use of the plasma in manufacturing. This regulatory framework is designed to minimize the risk of adventitious agent contamination in the final product.

Despite these controls, as with all human-derived biological materials, np001072 should be handled according to standard biosafety practices appropriate for potentially infectious human-origin material (typically BSL-2 precautions). Researchers should consult the product Safety Data Sheet (SDS) and their institutional biosafety guidelines before handling.

The supplier reference for this product is Athens Research catalog number 16-16-090707-FAB'2, which may be used to cross-reference certificates of analysis (CoA) and quality documentation available upon request from Aladdin Scientific.

Storage, Handling, and Stability Recommendations

Protein-based reagents such as IgG F(ab')₂ fragments require careful storage to maintain activity. General best practices for this class of reagent include:

• Store the product at the temperature specified on the product label and certificate of analysis. Protein fragments are typically stored at 2–8 °C for short-term use or at −20 °C for longer-term storage.
• Avoid repeated freeze-thaw cycles, as these can cause protein aggregation and loss of activity. Aliquot the material upon first thaw if long-term storage at −20 °C is required.
• Keep the product away from strong oxidizing agents and proteases.
• Centrifuge briefly before opening to collect any material from the cap or walls of the vial.

Note: Specific storage conditions, concentration, formulation buffer, and expiry information are provided on the product label and the accompanying certificate of analysis. Always defer to these documents for authoritative guidance.

Frequently asked questions

What is the difference between an F(ab')₂ fragment and a Fab fragment?

A Fab fragment is a monovalent antigen-binding unit produced by papain digestion of IgG, containing one light chain and one heavy chain fragment (VH-CH1) linked by a disulfide bond. An F(ab')₂ fragment is produced by pepsin digestion and retains two Fab' units covalently joined through hinge-region disulfide bonds, making it bivalent. The bivalency of F(ab')₂ allows it to cross-link antigens and may result in higher avidity compared to monovalent Fab, while both fragments lack the Fc region and therefore cannot engage Fc receptors or fix complement.

Why should I use F(ab')₂ fragments instead of intact IgG for blocking in flow cytometry or IHC?

Cells expressing Fc receptors (such as macrophages, monocytes, dendritic cells, B cells, and NK cells) can non-specifically bind the Fc region of intact IgG antibodies, producing high background signal that is unrelated to true antigen–antibody binding. Using F(ab')₂ fragments eliminates this Fc-mediated non-specific binding because the Fc region has been removed, resulting in lower background and more reliable signal-to-noise ratios in immunoassays involving Fc-receptor-positive cells or tissues.

Is the human plasma used to produce np001072 tested for infectious agents?

Yes. According to the product description, the source plasma is collected at FDA-certified blood collection centers, and the supplier performs donor screening and viral testing in compliance with current FDA requirements before the plasma is used in manufacturing. Despite these safety measures, the product should still be handled using biosafety precautions appropriate for human-derived biological materials, as stated in the product SDS and your institutional biosafety guidelines.

Can np001072 be used as a negative control in human IgG-based assays?

Human IgG F(ab')₂ fragments are commonly employed as isotype or non-specific binding controls in assays that use human IgG-derived antibodies, since they share the same immunoglobulin backbone without targeting a specific antigen. However, researchers should verify that the format (F(ab')₂ vs. intact IgG), concentration, and labeling state of np001072 match the experimental antibody before using it as a control. Consult the certificate of analysis for concentration and formulation details.

How should I store np001072 to maintain optimal activity?

Protein fragments should generally be stored at 2–8 °C for short-term use or at −20 °C for long-term storage, and repeated freeze-thaw cycles should be avoided by aliquoting the reagent upon first thaw. Always refer to the specific storage conditions printed on the product label and the certificate of analysis, as formulation and concentration may influence the recommended storage temperature and shelf life.

References

1. Athens Research & Technology. Product Reference 16-16-090707-FAB'2: IgG, F(ab')₂ Fragment, Human. Supplier documentation.
2. U.S. Food and Drug Administration. Guidance for Industry: Recommendations for the Assessment of Donor Suitability and Blood and Blood Product Safety in Cases of Known or Suspected West Nile Virus Infection. FDA, 2005. [Representative FDA blood safety guidance — specific guidance document applicable to this product's screening requirements should be verified.]
3. Harlow E, Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, 1988. [Standard reference for F(ab')₂ fragment preparation by pepsin digestion.]

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.